CIDARA THERAPEUTICS, INC. Accrued Liabilities, Current
CIDARA THERAPEUTICS, INC. had Accrued Liabilities, Current of $71.35 million as of 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2025-11-06
- 2025-09-30: Accrued Liabilities, Current $71.35M.
- 2025-06-30: Accrued Liabilities, Current $11.05M.
- 2025-03-31: Accrued Liabilities, Current $19.83M.
- 2024-12-31: Accrued Liabilities, Current $13.35M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2025-09-30 | $71.35M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $11.05M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $19.83M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $13.35M 10-Q · filed 2025-11-06 | |
| 2024-09-30 | $8.57M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $6.22M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $8.24M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $14.18M 10-K · filed 2025-03-06 | |
| 2023-09-30 | $11.77M 10-K · filed 2024-04-22 | |
| 2023-06-30 | $10.02M 10-K · filed 2024-04-22 | |
| 2023-03-31 | $9.11M 10-K · filed 2024-04-22 | $9.08M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $7.67M 10-K · filed 2024-04-22 | |
| 2022-09-30 | $8.16M 10-K · filed 2024-04-22 | |
| 2022-06-30 | $8.57M 10-K · filed 2024-04-22 | |
| 2022-03-31 | $9.95M 10-K · filed 2024-04-22 | $9.23M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $10.20M 10-K · filed 2023-03-23 | |
| 2021-09-30 | $8.53M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $8.10M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $9.05M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $7.96M 10-K · filed 2022-03-07 | |
| 2020-09-30 | $6.17M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $4.43M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $3.74M 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $4.07M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $4.32M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $3.58M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $3.79M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $3.88M 10-K · filed 2020-03-04 | |
| 2018-09-30 | $3.38M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $4.79M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $4.52M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $4.26M 10-K · filed 2019-02-28 | |
| 2017-09-30 | $3.19M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $3.46M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $3.44M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $3.34M 10-K · filed 2018-02-27 | |
| 2016-09-30 | $3.03M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $2.00M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $1.54M 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $1.42M 10-K · filed 2017-03-15 | |
| 2015-09-30 | $1.82M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $1.46M 10-Q · filed 2015-08-11 | |
| 2015-03-31 | $1.74M 10-Q · filed 2015-05-21 | |
| 2014-12-31 | $1.62M 10-K · filed 2016-03-18 |